{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:52:43Z","timestamp":1791823963101,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T00:00:00Z","timestamp":1477526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s13365-016-0489-5","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T09:17:22Z","timestamp":1477559842000},"page":"335-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Acyclovir resistance in herpes simplex virus type I encephalitis: a case report"],"prefix":"10.1007","volume":"23","author":[{"given":"M.","family":"Bergmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Helbok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pfausler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schmutzhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,27]]},"reference":[{"key":"489_CR1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/QCO.0000000000000015","volume":"26","author":"G Andrei","year":"2013","unstructured":"Andrei G, Snoeck R (2013) Herpes simplex virus drug-resistance: new mutations and insights. Curr Opin Infect Dis 26:551\u2013560","journal-title":"Curr Opin Infect Dis"},{"key":"489_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0140-6736(82)91620-8","volume":"1","author":"WH Burns","year":"1982","unstructured":"Burns WH, Saral R, Santos GW, Laskin OL, Lietman PS, McLaren C, Barry DW (1982) Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet 1:421\u2013423","journal-title":"Lancet"},{"key":"489_CR3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/AAC.42.4.868","volume":"42","author":"J Christophers","year":"1998","unstructured":"Christophers J, Clayton J, Craske J, Ward R, Collins P, Trowbridge M, Darby G (1998) Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother 42:868\u2013872","journal-title":"Antimicrob Agents Chemother"},{"key":"489_CR4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJM198202113060606","volume":"306","author":"CS Crumpacker","year":"1982","unstructured":"Crumpacker CS, Schnipper LE, Marlowe SI, Kowalsky PN, Hershey BJ, Levin MJ (1982) Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. N Engl J Med 306:343\u2013346","journal-title":"N Engl J Med"},{"key":"489_CR5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JCM.42.1.242-249.2004","volume":"42","author":"C Danve-Szatanek","year":"2004","unstructured":"Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I, Billaudel S, Chanzy B, Coste-Burel M, Finkielsztejn L, Fleury H, Hadou T, Henquell C, Lafeuille H, Lafon ME, Le FA, Legrand MC, Maille L, Mengelle C, Morand P, Morinet F, Nicand E, Omar S, Picard B, Pozzetto B, Puel J, Raoult D, Scieux C, Segondy M, Seigneurin JM, Teyssou R, Zandotti C (2004) Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 42:242\u2013249","journal-title":"J Clin Microbiol"},{"key":"489_CR6","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/infdis\/169.6.1338","volume":"169","author":"KH Fife","year":"1994","unstructured":"Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS (1994) Recurrence and resistance patterns of herpes simplex virus following cessation of > or =6\u00a0years of chronic suppression with acyclovir. Acyclovir Study Group. J Infect Dis 169:1338\u20131341","journal-title":"J Infect Dis"},{"key":"489_CR7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/infdis\/161.4.711","volume":"161","author":"A Gateley","year":"1990","unstructured":"Gateley A, Gander RM, Johnson PC, Kit S, Otsuka H, Kohl S (1990) Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS. J Infect Dis 161:711\u2013715","journal-title":"J Infect Dis"},{"key":"489_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4065\/84.1.16","volume":"84","author":"AY Joshi","year":"2009","unstructured":"Joshi AY, Iyer VN, Hagan JB, St Sauver JL, Boyce TG (2009) Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc 84:16\u201322","journal-title":"Mayo Clin Proc"},{"key":"489_CR9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcv.2004.03.002","volume":"30","author":"F Morfin","year":"2004","unstructured":"Morfin F, Bilger K, Boucher A, Thiebaut A, Najioullah F, Bleyzac N, Raus N, Bosshard S, Aymard M, Michallet M, Thouvenot D (2004) HSV excretion after bone marrow transplantation: a 4-year survey. J Clin Virol 30:341\u2013345","journal-title":"J Clin Virol"},{"key":"489_CR10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/AAC.00615-10","volume":"55","author":"J Piret","year":"2011","unstructured":"Piret J, Boivin G (2011) Resistence of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother 55:459\u2013472","journal-title":"Antimicrob Agents Chemother"},{"key":"489_CR11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJM199108223250805","volume":"325","author":"S Safrin","year":"1991","unstructured":"Safrin S, Crumpacker C, Chatis P (1991) A controlled trial comparing foscarnet with vidarabine for acyclovir resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 325:551\u2013555","journal-title":"N Engl J Med"},{"key":"489_CR12","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ana.21979","volume":"67","author":"EC Schulte","year":"2010","unstructured":"Schulte EC, Sauerbrei A, Hoffmann D, Zimmer C, Hemmer B, Muhlau M (2010) Acyclovir resistance in herpes simplex encephalitis. Ann Neurol 67:830\u2013833","journal-title":"Ann Neurol"},{"key":"489_CR13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coviro.2014.06.003","volume":"8","author":"HJ Scott","year":"2014","unstructured":"Scott HJ, Prichard MN (2014) Current and future therapies for therapies for herpes simplex virus infections: mechanism of action and drug resistance. Curr Opinion Virol 8:54\u201361","journal-title":"Curr Opinion Virol"},{"key":"489_CR14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/infdis\/146.5.673","volume":"146","author":"CD Sibrack","year":"1982","unstructured":"Sibrack CD, Gutman LT, Wilfert CM, McLaren C, St Clair MH, Keller PM, Barry DW (1982) Pathogenicity of acyclovir-resistant herpes simplex virus type 1 from an immunodeficient child. J Infect Dis 146:673\u2013682","journal-title":"J Infect Dis"},{"key":"489_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2004.04.002","volume":"32","author":"R Stranska","year":"2005","unstructured":"Stranska R, Schuurman R, Nienhuis E, Goedegebuure IW, Polman M, Weel JF, Wertheim-Van Dillen PM, Berkhout RJ, van Loon AM (2005) Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 32:7\u201318","journal-title":"J Clin Virol"}],"updated-by":[{"DOI":"10.1007\/s13365-017-0541-0","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T00:00:00Z","timestamp":1498694400000}}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-016-0489-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-016-0489-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-016-0489-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T23:08:58Z","timestamp":1568502538000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-016-0489-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,27]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1007\/s13365-016-0489-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726890452.793569909","asserted-by":"object"}]},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,27]]}}}